Machine Learning Distinguishes with High Accuracy between Pan-Assay Interference Compounds That Are Promiscuous or Represent Dark Chemical Matter.
暂无分享,去创建一个
Thomas Blaschke | Jürgen Bajorath | Swarit Jasial | Erik Gilberg | J. Bajorath | Swarit Jasial | T. Blaschke | Erik Gilberg
[1] B. Shoichet. Screening in a spirit haunted world. , 2006, Drug discovery today.
[2] J. Baell,et al. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. , 2010, Journal of medicinal chemistry.
[3] Vladimir N. Vapnik,et al. The Nature of Statistical Learning Theory , 2000, Statistics for Engineering and Information Science.
[4] Peter Wipf,et al. Profiling the NIH Small Molecule Repository for compounds that generate H2O2 by redox cycling in reducing environments. , 2010, Assay and drug development technologies.
[5] John P. Overington,et al. ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..
[6] B. Matthews. Comparison of the predicted and observed secondary structure of T4 phage lysozyme. , 1975, Biochimica et biophysica acta.
[7] Jayme L. Dahlin,et al. The Essential Medicinal Chemistry of Curcumin , 2017, Journal of medicinal chemistry.
[8] Erin E. Carlson,et al. Chemical probes of UDP-galactopyranose mutase. , 2006, Chemistry & biology.
[9] T. Tomašič,et al. Rhodanine as a privileged scaffold in drug discovery. , 2009, Current medicinal chemistry.
[10] Jürgen Bajorath,et al. How Frequently Are Pan-Assay Interference Compounds Active? Large-Scale Analysis of Screening Data Reveals Diverse Activity Profiles, Low Global Hit Frequency, and Many Consistently Inactive Compounds. , 2017, Journal of medicinal chemistry.
[11] C. Eyermann,et al. High-Throughput Identification of Promiscuous Inhibitors from Screening Libraries with the Use of a Thiol-Containing Fluorescent Probe , 2013, Journal of biomolecular screening.
[12] Robert Preissner,et al. Exploring Activity Profiles of PAINS and Their Structural Context in Target-Ligand Complexes , 2018, J. Chem. Inf. Model..
[13] Thomas Mendgen,et al. Privileged scaffolds or promiscuous binders: a comparative study on rhodanines and related heterocycles in medicinal chemistry. , 2012, Journal of medicinal chemistry.
[14] Christopher P Austin,et al. High-throughput screening assays for the identification of chemical probes. , 2007, Nature chemical biology.
[15] James Inglese,et al. Apparent activity in high-throughput screening: origins of compound-dependent assay interference. , 2010, Current opinion in chemical biology.
[16] Jürgen Bajorath,et al. Highly Promiscuous Small Molecules from Biological Screening Assays Include Many Pan-Assay Interference Compounds but Also Candidates for Polypharmacology. , 2016, Journal of medicinal chemistry.
[17] J. Bajorath,et al. X-ray Structures of Target-Ligand Complexes Containing Compounds with Assay Interference Potential. , 2018, Journal of medicinal chemistry.
[18] J. Baell,et al. Chemistry: Chemical con artists foil drug discovery , 2014, Nature.
[19] Alexander Tropsha,et al. Phantom PAINS: Problems with the Utility of Alerts for Pan-Assay INterference CompoundS , 2017, J. Chem. Inf. Model..
[20] Jonathan B Baell,et al. Feeling Nature's PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS). , 2016, Journal of natural products.
[21] J Willem M Nissink,et al. Seven Year Itch: Pan-Assay Interference Compounds (PAINS) in 2017—Utility and Limitations , 2017, ACS chemical biology.
[22] J. Irwin,et al. An Aggregation Advisor for Ligand Discovery. , 2015, Journal of medicinal chemistry.
[23] Jeffrey R. Huth,et al. Enhancement of chemical rules for predicting compound reactivity towards protein thiol groups , 2007, J. Comput. Aided Mol. Des..
[24] John J. Irwin,et al. ZINC 15 – Ligand Discovery for Everyone , 2015, J. Chem. Inf. Model..
[25] B. Shoichet,et al. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. , 2002, Journal of medicinal chemistry.
[26] Jayme L. Dahlin,et al. PAINS in the Assay: Chemical Mechanisms of Assay Interference and Promiscuous Enzymatic Inhibition Observed during a Sulfhydryl-Scavenging HTS , 2015, Journal of medicinal chemistry.
[27] Jürgen Bajorath,et al. Visualization and Interpretation of Support Vector Machine Activity Predictions , 2015, J. Chem. Inf. Model..
[28] Pierre Baldi,et al. Graph kernels for chemical informatics , 2005, Neural Networks.
[29] Nikhil Ketkar,et al. Introduction to PyTorch , 2021, Deep Learning with Python.
[30] B. Efron. Bootstrap Methods: Another Look at the Jackknife , 1979 .
[31] Yanli Wang,et al. PubChem BioAssay: 2017 update , 2016, Nucleic Acids Res..
[32] Jürgen Bajorath,et al. Determining the Degree of Promiscuity of Extensively Assayed Compounds , 2016, PloS one.
[33] Shaomeng Wang,et al. The Ecstasy and Agony of Assay Interference Compounds. , 2017, Journal of chemical information and modeling.
[34] Anne Mai Wassermann,et al. Dark chemical matter as a promising starting point for drug lead discovery. , 2015, Nature chemical biology.
[35] Michael K. Gilson,et al. Virtual Screening of Molecular Databases Using a Support Vector Machine , 2005, J. Chem. Inf. Model..
[36] David Rogers,et al. Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..